News
10d
GlobalData on MSNegnite introduces new research suite to improve patient identification in trialsThe platform's patient-focused outreach is beneficial in navigating the complexities of evolving eligibility criteria for ...
Mathematicians have invented a new statistical tool to analyze multiple outcomes from clinical trials, replacing the 60-year-old standard tool that could only look at binary outcomes (survived ...
To maximize the digital clinical trial opportunity, it is imperative to establish a solid foundation of data collection and management best practices and capitalize on the advancements in data ...
When shopping for clinical trial data visualization solutions, it's essential to be well-prepared. Here are some tips to help you make an informed decision.
Complexities in sample handling, instrument setup and data analysis are barriers to the effective use of flow cytometry to monitor immunological parameters in clinical trials. The novel use of a ...
The clinical trials arena is becoming increasingly data-driven, with demand growing for sponsors to have real-time data access throughout a study.
An artificial-intelligence tool called Trial Pathfinder can run clinical-trial emulations using health-care data from people with cancer, and can learn how to optimize trial-inclusion eligibility ...
CDISC and HL7 release FHIR to CDISC Joint Mapping Implementation Guide to facilitate use of electronic health record data in clinical research.
ImmuneOnco plans to release clinical data for AXN-2510/IMM2510 in NSCLC in 2025, initiating trials in China and the U.S.
Additionally, the Company announced positive clinical data from Part A of the REVEAL Phase 1/2 adolescent/adult and pediatric trials evaluating TSHA-102 in Rett syndrome.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results